Yogesh A Kulkarni

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 17

Top Venues

Chemistry & biodiversity

Naunyn-Schmiedeberg's archives of pharmacology

Archives of physiology and biochemistry

Journal of complementary & integrative medicine

SVKM's NMIMS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

SVKM's NMIMS Mar 1o 2018

India

Associate Professor :: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management

Publications

Ankit P Laddha, Yogesh A Kulkarni
Correction: Daidzein attenuates urinary bladder dysfunction in streptozotocin-induced diabetes in rats by NOX-4 and RAC-1 inhibition. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Ankit P Laddha, Yogesh A Kulkarni
Pharmacokinetics, pharmacodynamics, toxicity, and formulations of daidzein: An important isoflavone. Phytotherapy research : PTR (2023)
Ojaskumar D Agrawal, Yogesh A Kulkarni
Treatment with Terminalia chebula Extract Reduces Insulin Resistance, Hyperglycemia and Improves SIRT1 Expression in Type 2 Diabetic Rats. Life (Basel, Switzerland) 13 (5) (2023)
Manisha J Oza, Yogesh A Kulkarni
Biochanin A Attenuates Cardiomyopathy in Type 2 Diabetic Rats by Increasing SIRT1 Expression and Reducing Oxidative Stress. Chemistry & biodiversity 19 (3) (2022)
Pranali B Yeram, Yogesh A Kulkarni
Glycosides and Vascular Complications of Diabetes. Chemistry & biodiversity 19 (10) (2022)
Alok D Singh, Yogesh A Kulkarni
Vascular adhesion protein-1 and microvascular diabetic complications. Pharmacological reports : PR 74 (1) (2022)
Ankit P Laddha, Yogesh A Kulkarni
Daidzein attenuates urinary bladder dysfunction in streptozotocin-induced diabetes in rats by NOX-4 and RAC-1 inhibition. Naunyn-Schmiedeberg's archives of pharmacology 395 (8) (2022)
Sachin V Suryavanshi, Yogesh A Kulkarni
Abrogation of cardiomyopathy in diabetic rats by escin - possible role of NF-κβ and MCP-1. Archives of physiology and biochemistry (2021)
Shreya R Savla, Ankit P Laddha, Yogesh A Kulkarni
Pharmacology of apocynin: a natural acetophenone. Drug metabolism reviews 53 (4) (2021)
Samruddhi Kavishwar, Mrinal Sanaye, Monisha Nair, Mukesh Chawda, Viplav Kshirsagar, Yogesh A Kulkarni
The effect of Madhumeha Kusumakar Rasa - an Ayurved medicine - in insulin resistance. Journal of complementary & integrative medicine (2021)
Manisha J Oza, Yogesh A Kulkarni
Trifolium pratense (Red Clover) Improve SIRT1 Expression and Glycogen Content in High Fat Diet-Streptozotocin Induced Type 2 Diabetes in Rats. Chemistry & biodiversity 17 (4) (2020)
Kaveri M Adki, S Murugesan, Yogesh A Kulkarni
In Silico and In Vivo Toxicological Evaluation of Paeonol. Chemistry & biodiversity 17 (10) (2020)
Ankit P Laddha, Vivek V Nalawade, Milind Gharpure, Yogesh A Kulkarni
Development and Validation of HPLC Method for Determination of Sodium Copper Chlorophyllin - A Food Colorant and Its Application in Pharmacokinetic Study. Chemistry & biodiversity 17 (8) (2020)
Manisha J Oza, Yogesh A Kulkarni
Formononetin Ameliorates Diabetic Neuropathy by Increasing Expression of SIRT1 and NGF. Chemistry & biodiversity 17 (6) (2020)
Kaveri M Adki, Yogesh A Kulkarni
Biomarkers in diabetic neuropathy. Archives of physiology and biochemistry (2020)
Ankit P Laddha, Sankaranarayanan Murugesan, Yogesh A Kulkarni
In-vivo and in-silico toxicity studies of daidzein: an isoflavone from soy. Drug and chemical toxicology (2020)
Sachin V Suryavanshi, Milind Gharpure, Yogesh A Kulkarni
Sodium copper chlorophyllin attenuates adenine-induced chronic kidney disease via suppression of TGF-beta and inflammatory cytokines. Naunyn-Schmiedeberg's archives of pharmacology 393 (11) (2020)

Yogesh A Kulkarni.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yogesh A Kulkarni